DANIEL FLYNN

Profile

First Name

: DANIEL

Middle Name

:

Last Name

: FLYNN

Related Companies
Titles
Company Name
Related People
DIRECTOR
PROTEA BIOSCIENCES INC
STEVE ANTOLINE, JESSE AYERS, THOMAS CLARK, LEONARD P. HARRIS, STANLEY HOSTLER, STANLEY M. HOSTLER, RODERICK JACKSON, HARRIS LEO, MILAN PUSKAR, ED ROBERSON, SCOTT SEGAL, STEPHEN TURNER
DIRECTOR
PROTEA BIOSCIENCES GROUP, INC.
STEVE ANTOLINE, JOSIAH AUSTIN, JOSIAH T. AUSTIN, ALESSANDRO BALDI, TOM CLARK, PATRICK GALLAGHER, DAVID HALVERSON, LEONARD HARRIS, STEVE HARRIS, STANLEY HOSTLER, EDWARD HUGHES, RODERICK JACKSON, GREG KILBY, GREGORY KILBY, STEVE O-LOUGHLIN, MATTHEW POWELL, MILAN PUSKAR, ED ROBERSON, ED ROBERTSON, SCOTT SEGAL, MAGED SHENOUDA, JOHAN (THIJS) M. SPOOR, STEPHEN TURNER, STEPHEN A. TURNER, ANDREW ZULAUF, C. ANDREW ZULAUF
DIRECTOR
CUIVRE RIVER BANCSHARES, INC.
DANIEL R. FLYNN, DARRELL D. HARKE, DALE A. MCDONALD, DAVID R. MOLITOR, RANDALL W. MUELLER, WILLIAM C. VEHIGE, WAYNE R. WEHDE
EXECUTIVE OFFICER
FERNWEH DABICO HOLDINGS LLC
- FERNWEH DABICO LLC, - FERNWEH GROUP LLC, - MIRABILIS MANAGEMENT COMPANY LLC, SHEKHAR VARANASI
EXECUTIVE OFFICER
FERNWEH ENGAGED INVESTOR OPERATOR FUND II LP
- FERNWEH ENGAGED INVESTOR OPERATOR FUND II GP LLC, - FERNWEH ENGAGED INVESTOR OPERATOR FUND II-A GP LLC, PAVITRA KANDADAI, - MIRABILIS MANAGEMENT COMPANY LLC, NARENDRA K. SANTHANAM, SHEKHAR VARANASI
EXECUTIVE OFFICER
FERNWEH ENGAGED INVESTOR OPERATOR FUND II-A LP
- FERNWEH ENGAGED INVESTOR OPERATOR FUND II GP LLC, - FERNWEH ENGAGED INVESTOR OPERATOR FUND II-A GP LLC, PAVITRA KANDADAI, - MIRABILIS MANAGEMENT COMPANY LLC, NARENDRA K. SANTHANAM, SHEKHAR VARANASI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-14
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-23 
2025-10-14
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-23 
2024-07-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-23 
2024-07-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-23 
2024-06-18
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-14 
2022-02-11
D
Link
COMMERCIAL BANKING 
 
DECLINE TO DISCLOSE 
Debt 
2022-01-28 
2012-12-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-12-16 
2012-12-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-11-30 
2012-09-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2012-05-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
2012-01-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-12-27 
2011-11-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2010-11-10 
2011-09-16
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2011-09-02 
2011-05-05
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2011-04-28 
2011-01-14
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-03 
2009-08-12
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-03